RE: Opinions on Cineplex case?17 Aug 2021 13:39
I doubt that Frustration would work in this case - Canadian law may be different but has English Common Law at its root and Frustration only applies when a contract *cannot* be fulfilled - clearly Cineworld could have bought Cineplex as envisaged albeit it would be a really bad price to pay, but Covid didn't make it impossible.
However, I think Cine may get away with it for other reasons - this article covers some good points:
https://www.dlapiper.com/en/canada/insights/publications/2021/03/canadian-and-uk-courts-engage-on-covid19-in-mergers-and-acquisitions/
Tl;DR
2. Cineplex Inc.
Cineplex Inc v. Cineworld Group plc et al. (Court File No. CV-20-00643387-00CL) involves a $2.8 billion transaction where Cineworld sought to terminate the transaction on June 12, 2020. In that case, final order approval had already been obtained from the court prior to the termination, and the parties were in the process of obtaining the regulatory approvals necessary to close, when the termination notice was sent by Cineworld Group.
Unlike Rifco, Cineplex did not seek an order for specific performance and to force Cineworld to close. Cineplex accepted what it said was a wrongful termination, and sued for damages. The question of how to get an order in a reasonable period of time within the timeframes contemplated by the parties for Closing, requiring the parties to close, was therefore not raised. Other very interesting questions were raised, however. Beyond the usual questions about the scope of the MAE clause (in that case, the parties specifically excluded pandemic-related events from the scope of the MAE), the Cineplex case raises very interesting questions about the quantum of damages.
As we mentioned at the outset of this article, an Arrangement Agreement is typically between the purchaser and the target company. Shareholders are not usually parties to such agreements, and they are rarely parties in public company transactions. In its Statement of Claim, Cineplex seeks full recovery of the total amount of the purchase price of the transaction — $2.18 billion, with other relief pleaded in addition or in the alternative. Even suing for the premium of the transaction that shareholders would have enjoyed raises questions: are those really the company’s damages at all? And even if the company could make such a claim for shareholders, the shareholders still have the control premium, and in theory could sell it again. Are there issues of double recovery in such a case? There are interesting questions to be resolved, in addition to all of the other questions that a MAE case would normally raise, of the kinds described earlier.
Even though Cineplex has not sought specific performance, it is proceeding at a relatively rapid pace, with a trial expected this fall.